← All news

FROM THE NEWS FEED

How might Heidi Overton’s FDA Commissioner nomination shape psychedelics policy? And what is 4-OH-DiPT?

2026-08-28 • The Microdose (Berkeley)

Article summary

Plus: Can psilocybin therapy move from clinical trials to clinics? And pharmacists argue for a role in psychedelic therapy

Continue to the original publication for the complete article.